We are live on
!
Find out more
Vanda Pharmaceuticals
VNDA
VNDA
153 hedge funds and large institutions have $369M invested in Vanda Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 64 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
909% more call options, than puts
Call options by funds: $10.5M | Put options by funds: $1.04M
65% more capital invested
Capital invested by funds: $225M → $369M (+$145M)
22% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 23
2% more funds holding
Funds holding: 150 → 153 (+3)
5.09% less ownership
Funds ownership: 75.97% → 70.89% (-5.1%)
39% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 64
Holders
153
Holders Change
+3
Holders Change %
+2%
% of All Funds
1.86%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
39
Reduced
64
Closed
23
Calls
$10.5M
Puts
$1.04M
Net Calls
+$9.48M
Net Calls Change
+$10.4M
Top Buyers
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$11.7M |
| 2 |
Millennium Management
New York
|
-$8.65M |
| 3 |
BlackRock
New York
|
-$6.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.45M |
